Ignite Creation Date:
2024-05-05 @ 7:27 PM
Last Modification Date:
2024-10-26 @ 9:49 AM
Study NCT ID:
NCT00673790
Status:
COMPLETED
Last Update Posted:
2020-02-26
First Post:
2008-04-29
Brief Title:
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Sponsor:
Forest Laboratories
Organization:
Forest Laboratories
Study Overview
Official Title:
Blood Pressure and Metabolic Effects of Nebivolol Compared With Hydrochlorothiazide and Placebo in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Status:
COMPLETED
Status Verified Date:
2020-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is being done to see if the blood pressure and metabolic effects of an approved drug nebivolol is comparable to that of another approved drug hydrochlorothiazide HCTZ and placebo in hypertensive patients
Detailed Description:
This study is double blind neither you nor the physician will know when you are receiving placebo which is an inactive compound such as a sugar pill or active study drugs nebivolol or hydrochlorothiazide
All participants will also receive lisinopril an angiotensin converting enzyme or losartan an angiotensin receptor blocker All medications are approved and marketed for the treatment of hypertensionThis study is being conducted in about 500 patients at approximately 80 research centers in the United States
The study consists of approximately 9 study visits over a period of 5 months During these visits patients will undergo routine health exams and some special laboratory tests such as an oral glucose tolerance test
All participants will also receive lisinopril an angiotensin converting enzyme or losartan an angiotensin receptor blocker All medications are approved and marketed for the treatment of hypertensionThis study is being conducted in about 500 patients at approximately 80 research centers in the United States
The study consists of approximately 9 study visits over a period of 5 months During these visits patients will undergo routine health exams and some special laboratory tests such as an oral glucose tolerance test
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None